Marine n-3 long-chain polyunsaturated fatty acid intake in pregnancy and risk of early life infections in three Nordic cohorts: a HEDIMED consortium study
| dc.contributor.author | Rantala, Aino K. | |
| dc.contributor.author | Hakola, Leena | |
| dc.contributor.author | Brustad, Nicklas | |
| dc.contributor.author | Tapia, German | |
| dc.contributor.author | Hård af Segerstad, Elin M. | |
| dc.contributor.author | Lehtonen, Jussi | |
| dc.contributor.author | Thorsen, Jonathan | |
| dc.contributor.author | Åkerlund, Mari | |
| dc.contributor.author | Parr, Christine L. | |
| dc.contributor.author | Magnus, Maria C. | |
| dc.contributor.author | Lund-Blix, Nicolai A. | |
| dc.contributor.author | Stokholm, Jakob | |
| dc.contributor.author | Knip, Mikael | |
| dc.contributor.author | Toppari, Jorma | |
| dc.contributor.author | Størdal, Ketil | |
| dc.contributor.author | Veijola, Riitta | |
| dc.contributor.author | Hyöty, Heikki | |
| dc.contributor.author | Virtanen, Suvi M. | |
| dc.contributor.author | Bønnelykke, Klaus | |
| dc.contributor.author | Stene, Lars C. | |
| dc.contributor.author | HEDIMED Investigator Group | |
| dc.contributor.organization | fi=biolääketieteen laitos|en=Institute of Biomedicine| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization | fi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)| | |
| dc.contributor.organization | fi=InFLAMES Lippulaiva|en=InFLAMES Flagship| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.68445910604 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.77952289591 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.42471027641 | |
| dc.converis.publication-id | 515684061 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/515684061 | |
| dc.date.accessioned | 2026-04-24T17:27:19Z | |
| dc.description.abstract | <h3>Background</h3><p><em>n-3</em> long-chain polyunsaturated fatty acids (<em>n-3</em> LCPUFA) have anti-inflammatory effects that may influence immune-mediated diseases.</p><h3>Objective</h3><p>We investigated whether higher maternal pregnancy intake of <em>n-3</em> LCPUFA is associated with a lower infection incidence in young children.</p><h3>Methods</h3><p>We used data from three Nordic cohorts: the Norwegian Mother, Father and Child Cohort study (MoBa, n=76,026), the Finnish Diabetes Prediction and Prevention study (DIPP, n=560) and the Copenhagen Prospective Studies on Asthma in Childhood 2010 cohort (COPSAC2010, n=680). Childhood infections up to age 36 months were assessed using questionnaires in MoBa, coxsackievirus B 1-6 (CVB1-6) neutralizing antibodies in DIPP, and pathogenic viral PCR identification from acute respiratory episodes in COPSAC2010. Maternal <em>n-3</em> LCPUFA intake was assessed through validated food frequency questionnaires in MoBa and DIPP, while COPSAC2010 used a randomized trial design where pregnant women received fish oil capsules or placebo.</p><h3>Results</h3><p>Higher <em>n-3</em> LCPUFA intake was not significantly associated with lower respiratory tract infection (adjusted incidence rate ratio (aIRR) 0.99; 95% CI 0.94-1.03) but was associated with a reduced risk of upper respiratory tract infections (aIRR 0.99; 95% CI 0.98-0.99) and gastroenteritis (aIRR 0.96; 95% CI 0.95-0.98) per g/day up to age 36 months in MoBa. The DIPP study found no association between <em>n-3</em> LCPUFA intake and having ≥1 CVB infection (adjusted odds ratio 1.74; 95% CI 0.64-4.72, per g/day). The COPSAC2010 trial found no significant effects of the intervention for pathogen specific respiratory episodes (IRR 0.86; 95% CI 0.69-1.07).</p><h3>Conclusions</h3><p>This study does not provide consistent evidence that higher maternal <em>n-3</em> LCPUFA</p> | |
| dc.identifier.eissn | 1541-6100 | |
| dc.identifier.jour-issn | 0022-3166 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/58953 | |
| dc.identifier.url | https://doi.org/10.1016/j.tjnut.2026.101456 | |
| dc.identifier.urn | URN:NBN:fi-fe2026042332962 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Toppari, Jorma | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.discipline | 3142 Public health care science, environmental and occupational health | en_GB |
| dc.okm.discipline | 3142 Kansanterveystiede, ympäristö ja työterveys | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | Elsevier BV | |
| dc.publisher.country | United States | en_GB |
| dc.publisher.country | Yhdysvallat (USA) | fi_FI |
| dc.publisher.country-code | US | |
| dc.relation.articlenumber | 101456 | |
| dc.relation.doi | 10.1016/j.tjnut.2026.101456 | |
| dc.relation.ispartofjournal | Journal of Nutrition | |
| dc.relation.issue | 5 | |
| dc.relation.volume | 156 | |
| dc.title | Marine n-3 long-chain polyunsaturated fatty acid intake in pregnancy and risk of early life infections in three Nordic cohorts: a HEDIMED consortium study | |
| dc.year.issued | 2026 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- 1-s2.0-S0022316626001057-main.pdf
- Size:
- 1.38 MB
- Format:
- Adobe Portable Document Format